Jump to content

BabcockHall

Senior Members
  • Posts

    648
  • Joined

  • Last visited

2 Followers

Profile Information

  • Favorite Area of Science
    bioorganic chemistry

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

BabcockHall's Achievements

Molecule

Molecule (6/13)

51

Reputation

  1. I decided to try a test run today. The stacking gel is only a few millimeters in length. I started at 150 volts and about 60 milliamps, and it seemed as if the current decreased over time. The gel ran more quickly than what I was used to. I am destaining the gel now, and the bands look good.
  2. I am trying precast gels for the first time, and it is for a laboratory class. I talked to someone in technical services, and he sent a pdf with some instructions. As I read them, I did not see anything about changing the voltage between the stacking gel and the resolving gel. I will try something similar to what you suggest.
  3. I have cast and used SDS PAGE with Tris/glycine/SDS electrode buffer. However, I was planning to use some precast, gradient gels for the first time. I am trying to contact the manufacturer, but I have not yet heard back. "BisTris" is in the product description, and the catalog page mentions the possibility of ordering MES or MOPS buffer. My first question is whether I should change my recipe for the sample loading buffer. My old recipe includes Tris (pH 6.8, same as stacking gel), SDS, 2-mercaptoethanol, glycerol, and bromphenol blue. My second question is what sort of power settings should I use? In the past I have typically used about 100 volts during the stacking portion of the run, which changes to 150 volts or more volts once the samples enter the resolving gel.
  4. I tried the option of print to pdf today. I chose the landscape option. I still cannot fill more than about half the page with the spectrum. On the other hand, I was able to get better results with Microsoft's Snip tool than I had previously: I resized the scan within the Cary software. I will keep working on this.Fraction_17_gelfiltration_landscape.pdfFraction_17_gelfiltration_landscape.pdf
  5. Thank you; this is helpful in a couple of ways. One, it notes that one cannot directly export the spectrum as a jpg or png, which is what I thought. Two, it confirms that the spectrum can be exported as a csv file. The problem with csv files is that they take a bit of editing before one gets a usable spectrum (this is not ideal in a classroom application).
  6. After a long hiatus, I am using Cary spectrophotometers again. I am struggling to find the best way to export just a spectrum electronically, especially an electronic format that could be imported into a Word document. As a work-around, I used Microsoft's Snip and Sketch tool (not sure that this is the correct name) to make .jpg or .png files, but this is an imperfect solution. When I tried to export the Report as a .pdf file, I obtained the spectrum plus parameters, and for right now, it is just the spectrum that I want. I tried two other formats, .DSW and .RTF, but I was not successful. The details escape me at the moment, but I will try to return to this question later. For a very different program I used .wmf format (Windows Meta File), but that is not available in this instance. Any thoughts? Thank you in advance.
  7. The assays that I have in mind are disk diffusion assays and assays to determine minimum inhibitory concentration or related. Sometimes these assays are conducted in rich medium (Luria broth, Terrific Broth, or similar). It seems to me that this choice biases against finding inhibitors that target enzymes whose absence is conditionally lethal. If one inhibits an enzyme that produces a metabolite that can be obtained from the medium, then growth of the cells might be impaired little or not at all. If one is interested in developing an antimicrobial compound, perhaps using a medium that mimics human serum is a better choice, but I imagine that there are complications I doubt very much that I am the only person who has wondered about this possible problem. Are there any papers that touch upon this subject or address it in a systematic manner.
  8. Faucher and Maitre Synthetic Communications 2003 33(20):3503-3511. DOI:10.1081/SCC-120024730 I would consider the possibility that TCEP is reducing DMSO, although the presence of iodine may be necessary for a rapid reaction (see Faucher and Maitre). If I could find no more information on this topic, I would consider switching my solvent to DMF. Is there any reason that you are using TCEP and not 2-ME or DTT as your reducing agent?
  9. Tutoring is not a replacement for studying on your own, IMO. It can fill in the gaps when you get stuck. My advice is to turn off all electronic distractions; short, intense studying is more effective than long periods of diffuse studying.
  10. If I recall correctly I once used bromocresol green to detect compounds containing a carboxylic acid group on a TLC plate. That is probably different from the sort of reaction that you were thinking about.
  11. A catalyst such as thiamine pyrophosphate can decarboxylate alpha-keto acids.
  12. Hi CharonY, Thank you for a very helpful answer. We used established antimicrobial substances as positive controls; we were not comparing our compounds to them in any other sense.
  13. Many covalent inhibitors are irreversible, but not all of them are. If each step to form a covalent bond is reversible, then the whole process is reversible. A good example is peptide aldehyde or trifluromethylketone binding to the nucleophile in a cysteine or serine proteases. Reversible, covalent inhibitors seem to be catching on, so it's a good topic.
  14. My suggestion is to rewrite the standard Michaelis-Menten equation in the form (velocity)/Vmax = and so forth. To do so is trivial from the point of view of the algebra involved.
  15. Good Morning, We are collaborating with a group that performs disk diffusion assays on compounds that we make. We would like to publish some disk diffusion data in addition to reporting on the syntheses and perhaps the in vitro behavior of a set of compounds. However, the area of whole-cell biological testing is generally unfamiliar to me, and I don't know how to present data in a manuscript. I also don't have a good feel for what information should or should not be included in reporting these data. Perhaps someone could suggest a model publication, for example. Thank you.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.